SCHEMBL28069963

SCHEMBL28069963

CCOC[CH]c1cccc(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
HPGD P15428 1/20 0.42
SLC6A19 Q695T7 1/20 0.42
HSD11B1 P28845 1/20 0.41
MAPT P10636 2/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
CHRNA7 P36544 1/20 0.40
HSD17B3 P37058 1/20 0.40
MAOA P21397 2/20 0.39
MAOB P27338 1/20 0.39
XDH P47989 2/20 0.38
PKM P14618 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
EGFR P00533 1/20 0.37
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204838 0.83 ALDH1A1 (0.47) ALDH1A1SLC6A19HSD11B1MAPTPOLB
SCHEMBL27696264 0.83 SLC6A19 (0.50) ALDH1A1HPGDSLC6A19HSD11B1MAPT
SCHEMBL16618643 0.81 ALDH1A1 (0.61) ALDH1A1SLC6A19HSD11B1MAPTPOLB
SCHEMBL18243744 0.77 ALDH1A1 (0.57) ALDH1A1SLC6A19HSD11B1MAPTPOLB
SCHEMBL1230594 0.77 RELA (0.44) ALDH1A1KDM4EMAOAMAOBCYP1A2
SCHEMBL6204519 0.75 ALDH1A1 (0.42) ALDH1A1HPGDSLC6A19HSD11B1MAPT
SCHEMBL28769190 0.72 ALDH1A1 (0.61) ALDH1A1SLC6A19HSD11B1MAPTPOLB
SCHEMBL9305792 0.71 CYP1A2 (0.55) ALDH1A1SLC6A19HSD11B1MAPTPOLB
SCHEMBL2793141 0.71 ALDH1A1 (0.43) ALDH1A1HPGDMAPTPOLBKDM4E
SCHEMBL2793139 0.71 ALDH1A1 (0.43) ALDH1A1HPGDMAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105555766-A Aminomethyl-biaryl derivatives as complement factor D inhibitors and uses thereof NOVARTIS AG 2016-05-04 CN disclosed